FIELD: chemistry.
SUBSTANCE: invention relates to derivatives of general formula I, which can be used in treating prostaglandin mediated diseases,
where R1, R2, R3 and R4 independently denote hydrogen, alkyl, halogenalkyl, halogen, nitro, cyano, formyl, methylsulphonyl or methylcarbonyl; n is an integer from 0 to 5; r equals 0 or 1; R5, R6 and R7 independently denote hydrogen; alkyl; alkenyl; cyclohexyl; optionally substituted aryl, aryloxy; alkoxycarbonyl; phenylcarbonyl; N-alkyl-N-phenylcarbamoyl; N-alkyl-N-phenylalkylcarbamoyl; N-phenylalkyl-N-phenylcarbamoyl; optionally substituted furanyl, oxazolyl or pyridinyl; 1-alkoxycarbonylindazol-3-yloxy; 3,4-dihydro-2H-quinolin-1-ylcarbonyl; or a substituted amine; two of R5-R7 together with a carbon atom to which they are bonded form cycloakyl, substituted piperidinyl or pyrrolidinyl.
EFFECT: obtaining new biologically active compounds.
12 cl, 285 ex, 69 tbl
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 2-ANILINOBENZIMIDAZOLES, THEIR USING AS INHIBITORS OF NA/H-EXCHANGE AND MEDICINAL AGENT COMPRISING THEREOF | 2001 |
|
RU2272031C2 |
TETRAHYDROPYRIDOINDOLE DERIVATIVES | 2005 |
|
RU2387652C2 |
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2404163C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
HETEROCYCLIC COMPOUNDS AND APPLICATION METHODS | 2002 |
|
RU2345983C2 |
PYRIDINCARBOXAMIDES AS 11-BETA-HSD1 INHIBITORS | 2007 |
|
RU2451674C2 |
DERIVATIVES OF INDOLE-1-YLACETIC ACID | 2005 |
|
RU2376286C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BENZODIAZEPINE DERIVATIVES AND RSV FUSION PROTEIN INHIBITOR | 2005 |
|
RU2388476C2 |
DERIVATIVES OF BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2002 |
|
RU2265018C2 |
NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
Authors
Dates
2011-01-20—Published
2005-08-23—Filed